FDA issued a Warning Letter to Frontida BioPharm Inc on 8/15/2016 for a later inspection.
483 Frontida BioPharm Jul 2014

483 Frontida BioPharm Jul 2014

Gayle Lawson FDA, Temar Williams FDA$119.00 - Available Now

FDA investigators audited the Frontida BioPharm - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 25 Jul 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jul 2014
  • Location: Philadelphia, United States
  • FEI: 2523348
Add To Cart